MRM Medirom Healthcare Technologies

MEDIROM Healthcare Technologies Inc. Announces August 2022 Key Performance Indicators (KPIs)

MEDIROM Healthcare Technologies Inc. Announces August 2022 Key Performance Indicators (KPIs)

Total Customers Served: 72,250 – Sales Per Customer: JPY 6,705 – Customer Repeat Ratio: 80.1%

NEW YORK, Sept. 20, 2022 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (the “Company”), today announced its major Key Performance Indicators, or KPIs, updated for the month of August 2022. Data is provided for all salons for which comparative financial and customer data is available and excludes certain salons where such information is not available.

The following monthly KPIs provide insight into the business fundamentals and progress of the Company, updated for the month of August 2022.

  • The number of salons was 311 in August 2022, down from 315 in the year-ago period. From August 2021 to August 2022, 14 unprofitable salons were closed through scrap-and-build and 10 new salons were opened.
  • Total customers served increased to 72,250 in August 2022 from 66,323 in the year-ago period. The increase is primarily attributed to the increase in the number of salons with available financial and customer data and economic recovery from COVID-19 pandemic.
  • Sales per customer increased to JPY 6,705 in August 2022 from JPY 6,592 in August 2021. The increase is primarily attributed to the upselling of value-added optional services.
  • Repeat ratio, a measure of repeat customers, decreased to 80.1% in August 2022 from 81.3% in the year-ago period.
  • Operation ratio increased to 49.8% in August 2022 from 46.5% in the year-ago period. The increase is primarily attributed to the adjustment of staffing according to salon scale.
  • The total number of salons with data increased to 232 in August 2022 from 221 in August 2021. The increase is attributed to the completion of the replacement of the customer management system in certain salons. The number of salons with data decreases when we close salons with data available and increases as we open salons with such data.
 Number of Salons (*1)Number of Salons with Data (*2)Total Customers Served (*3)Sales per Customer (*4)Repeat Ratio (*5)Operation Ratio (*6)
August-2131522166,323JPY 6,59281.3%46.5%
September-2131622165,130JPY 6,42882.0%46.7%
October-2131622168,608JPY 6,48683.3%48.9%
November-2131622165,569JPY 6,46681.9%47.7%
December-2131222171,173JPY 6,63481.7%50.5%
January-2231222162,747JPY 6,57082.4%48.2%
February-2231021954,443JPY 6,66283.8%46.4%
March-2231021761,417JPY 6,59582.4%46.5%
April-2230923269,986JPY 6,61682.0%48.3%
May-2230823277,291JPY 6,46179.6%50.1%
June-2230723173,259JPY 6,51180.4%50.3%
July-2230923176,521JPY 6,66880.6%50.3%
August-2231123272,250JPY 6,70580.1%49.8%

(*1) Number of Salons: Includes our directly-operated salons and franchisees’ salons.

(*2) Number of Salons with Data: The number of salons for which comparable financial and customer data is available.

(*3) Total Customers Served: The number of customers served at salons for which comparative financial and customer data is available.

(*4) Sales Per Customer: The ratio of total salon sales to number of treated customers at all salons for which comparable financial and customer data is available.

(*5) Repeat Ratio: The ratio of repeat customer visits to total customer visits in the applicable month for all salons for which comparable financial and customer data is available.

(*6) Operation Ratio: The ratio of therapists’ in-service time to total therapists’ working hours (including stand-by time) for the applicable month for all salons for which comparable financial and customer data is available.

*Since July 2021, the salon operation business has been managed by Wing Inc., which is a wholly-owned subsidiary of the Company.

About MEDIROM Healthcare Technologies Inc.

MEDIROM, a holistic healthcare company, operates 311 (as of August 31, 2022) relaxation salons across Japan, Re.Ra.Ku®, being its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health tech business, and launched new healthcare programs using on-demand training app called “Lav®”, which is developed by the Company. MEDIROM also entered the device business in 2020 and is developing a smart tracker “MOTHER Bracelet®” (formerly known as “MOTHER Tracker®”). MEDIROM hopes that its diverse health related services and products offering will help it collect and manage healthcare data from users and customers and enable it to become a leader in big data in the healthcare industry. For more information, visit

Forward-Looking Statements

Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about the Company’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to the Company’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company’s control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company’s operations, results of operations, growth strategy and liquidity. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Photos accompanying this announcement are available at:

 



Contacts
Investor Relations Team
 
EN
20/09/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Medirom Healthcare Technologies

 PRESS RELEASE

MEDIROM Healthcare Technologies Inc. Announces 22% Rise in Revenue and...

MEDIROM Healthcare Technologies Inc. Announces 22% Rise in Revenue and 20% Improvement in Earnings for 2024; Webcast to Discuss Financial Results to be held on May 21st, 2025 at 8:30 AM ET TOKYO, May 20, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the “Company” or “MEDIROM”), today announced that for the year ended December 31, 2024, the Company had total revenue of $52,736,000, a 22% increase over total revenue of $43,388,000 for the year ended December 31, 2023. (The Company reports its financial results i...

 PRESS RELEASE

MEDIROM Healthcare Technologies Inc. to Host Webcast on May 21, 2025 a...

MEDIROM Healthcare Technologies Inc. to Host Webcast on May 21, 2025 at 8:30 AM ET to Discuss 2024 Financial Results TOKYO, May 19, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the “Company” or “MEDIROM”) today announced that it will host a webcast to review the Company’s financial results for the fiscal year ended December 31, 2024, on Wednesday, May 21, 2025 at 8:30 am Eastern Time. The Company will issue a press release discussing those results after the market close on Tuesday, May 20th, 2025. In additio...

 PRESS RELEASE

MEDIROM Healthcare Technologies Inc. Announces New JPY350 Million (App...

MEDIROM Healthcare Technologies Inc. Announces New JPY350 Million (Approximately $2.4 Million*) Unsecured Loan Financing TOKYO, March 17, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the “Company” or “MEDIROM”), today announced that it has obtained a new unsecured short-term bank loan in the amount of JPY350 million (approximately $2.4 million*). The Company has used JPY200 million of the loan funds for repayment of indebtedness of MEDIROM Mother Labs Inc., a subsidiary of the Company which is also a guaranto...

 PRESS RELEASE

MEDIROM Mother Labs Executive Makes Additional Investment in Mother La...

MEDIROM Mother Labs Executive Makes Additional Investment in Mother Labs’ Series A Financing at a Pre-Money Valuation of JPY9 Billion (as of March 13, 2025, Approximately US$60 Million) TOKYO, March 13, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (the “Company” or “MEDIROM”) announces that Yasuhiro Hayami, Chief Business Officer of MEDIROM Mother Labs Inc. (“Mother Labs”), a subsidiary of the Company, has made a second investment in Mother Labs’ Series A financing at a pre-money valuation of JPY9 billion (as of March 13, 2025, approximately US$60 million). ...

 PRESS RELEASE

MEDIROM Healthcare Technologies Inc. Announces Preliminary, Unaudited ...

MEDIROM Healthcare Technologies Inc. Announces Preliminary, Unaudited Financial Results for Full Year 2024 Under Japanese GAAP Sustained Revenue Growth / Operating Profitability NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the “Company”), today announced its preliminary, unaudited consolidated financial results for the year ended December 31, 2024, prepared under Japanese generally accepted accounting principles (“JGAAP”). These preliminary financial results and management’s estimates inc...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch